HIV and Diabetes Drugs May Lower the Risk of Developing AMD
Wednesday, June 30 2021 | 11 h 15 min | Vision Science
Two research groups have used data from American health insurance claims to see if individuals on specific drugs have a lower risk of developing...
Read More
AMD Clinical Trial Update on Next-GEN Anti-VEGF Treatment
Wednesday, June 23 2021 | 11 h 09 min | Vision Science
Roche has released the results of a Phase 3 trial of a next-generation anti-VEGF treatment, faricimab, for wet age-related macular degeneration (wet...
Read More
Cholesterol Lowering Statin Drug May Promote Retinal Neuron Regeneration
Wednesday, June 9 2021 | 13 h 06 min | Vision Science
FBC funded researcher Dr Philippe Monnier has published a study in the journal Neurobiology of Disease that shows that cholesterol inhibition...
Read More
HOYA Releases Results of Three-Year MiYOSMART Spectacle Lens Follow-up Study
Tuesday, April 27 2021 | 10 h 22 min | News, Press Release, Vision Science
HOYA Vision Care announced during the European Academy of Optometrists and Optics (AOO21) the results of a three-year follow-up clinical study on...
Read More
Bausch + Lomb Announces Results from First Phase 3 Trial of NOV03
Thursday, April 15 2021 | 09 h 33 min | Dry Eye, News, Press Release
Bausch + Lomb and Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics, announced statistically significant...
Read More
